Show simple item record

dc.contributor.authorGreenfield, C
dc.contributor.authorOsidiana, V
dc.contributor.authorKarayiannis, P
dc.contributor.authorGalpin, S
dc.contributor.authorMusoke, R
dc.contributor.authorJowett, TP
dc.contributor.authorMati, P
dc.contributor.authorTukei, PM
dc.contributor.authorThomas, HC
dc.date.accessioned2013-06-18T08:41:48Z
dc.date.available2013-06-18T08:41:48Z
dc.date.issued1986-06
dc.identifier.citationJ Med Virol. 1986 Jun;19(2):135-42en
dc.identifier.urihttp://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/3723115
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/35443
dc.description.abstractIn Kenya hepatitis B virus (HBV) infection and its sequelae are common. We followed up 49 hepatitis B surface antigen (HBsAg)- positive mothers and their newborn infants for 9 months to determine the importance of perinatal transmission in the African and to relate this to the HBe and HBV-DNA status of the mother. Our study shows that perinatal transmission is relatively unimportant in Kenya and that this may be a consequence of the low levels of circulating HBV-DNA in the maternal plasma. These results imply that vaccination without hyperimmune globulin may be adequate to control HBV infection in Kenyaen
dc.language.isoenen
dc.publisherUniversity Of Nairobien
dc.titlePerinatal Transmission Of Hepatitis B Virus In Kenya: Its Relation To The Presence Of Serum Hbv-dna And Anti-hbe In The Motheren
dc.typeArticleen
local.publisherFaculty Of Medicineen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record